SCHEMBL19712992

SCHEMBL19712992

C=C(C)C(=O)OCC(C)OC(=O)Nc1ccccc1Sc1cccc(Sc2ccccc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 10/20 0.46
TDP1 Q9NUW8 4/20 0.42
ALDH1A1 P00352 7/20 0.41
KMT2A Q03164 6/20 0.41
MEN1 O00255 3/20 0.41
BLM P54132 1/20 0.41
LMNA P02545 4/20 0.41
HPGD P15428 3/20 0.41
ATM Q13315 1/20 0.41
MAPT P10636 1/20 0.40
POLB P06746 2/20 0.40
KDM4E B2RXH2 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
MAPK1 P28482 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19713001 0.95 L3MBTL1 (0.50) L3MBTL1TDP1ALDH1A1KMT2AMEN1
SCHEMBL19713027 0.87 L3MBTL1 (0.47) L3MBTL1TDP1ALDH1A1KMT2AMEN1
SCHEMBL19712972 0.85 TDP1 (0.46) L3MBTL1TDP1ALDH1A1KMT2AMEN1
SCHEMBL22318930 0.83 L3MBTL1 (0.48) L3MBTL1TDP1ALDH1A1KMT2AMEN1
SCHEMBL19712999 0.81 L3MBTL1 (0.51) L3MBTL1TDP1ALDH1A1KMT2AMEN1
SCHEMBL22318927 0.79 L3MBTL1 (0.44) L3MBTL1TDP1ALDH1A1KMT2AMEN1
SCHEMBL22318929 0.79 L3MBTL1 (0.44) L3MBTL1TDP1ALDH1A1KMT2AMEN1
SCHEMBL19712980 0.79 ALDH1A1 (0.50) L3MBTL1TDP1ALDH1A1KMT2AMEN1
SCHEMBL17847450 0.77 L3MBTL1 (0.53) L3MBTL1TDP1ALDH1A1KMT2AMEN1
SCHEMBL19712958 0.77 CHRM3 (0.45) L3MBTL1MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107223121-B Wet stable holographic media 科思创德国股份有限公司 2020-10-27 CN disclosed
EP-3233791-B1 MOISTURE STABLE HOLOGRAPHIC MEDIA COVESTRO DEUTSCHLAND AG (DE) 2020-08-12 EP disclosed
US-10329244-B2 Moisture-stable holographic media COVESTRO DEUTSCHLAND AG (DE) 2019-06-25 US disclosed
US-20170362165-A1 MOISTURE-STABLE HOLOGRAPHIC MEDIA COVESTRO DEUTSCHLAND AG (DE) 2017-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329244-B2 Moisture-stable holographic media NEFM, MDM4, BHMT2 L3MBTL1 4042/4885TDP1 1478/4885ALDH1A1 3155/4885
US-20170362165-A1 MOISTURE-STABLE HOLOGRAPHIC MEDIA NEFM, MDM4, BHMT2 L3MBTL1 4042/4885TDP1 1478/4885ALDH1A1 3155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.